Dewpoint Therapeutics
Anneke joined Dewpoint in November 2021 as Associate Director, Project Management.
Prior to Dewpoint, Anneke worked as Project Manager at the Center for the Development of Therapeutics (CDoT) at the Broad Institute of MIT and Harvard, translating academic research into drug discovery projects collaborating with pharma and venture capital as well as philanthropic organizations. A life scientist turned project manager, Anneke is passionate about how project management can provide the tools and resources for researchers to better organize their projects, while being flexible and evolving with the projects as needed.
Anneke is also a scientific communication coach who helps others become better communicators of their amazing science, and sits on the Board of Directors for the German American Business Council of Boston (GABC), an organization dedicated to encouraging and cultivating German-American business.
Anneke graduated from Kiel University with a Diploma in Biology, and she obtained a PhD in Medical Sciences from the University of Oxford, UK. Her postdoctoral training was at the Broad Institute of MIT and Harvard in the laboratory of Stuart Schreiber.
This person is not in any offices
Dewpoint Therapeutics
Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions has pathways that are regulated by condensates or arise from the dysfunction of condensates - including cancer, neurodegeneration, and metabolic disease.